MLchartDataset catalogue

Tavalisse

Term · Oncology and biomedicine · MLC-T-ONC-008532

A drug used to treat thrombocytopenia (a low blood platelet count) in adults with chronic immune thrombocytopenia (ITP) that did not get better with other treatment. ITP is a condition in which platelets are destroyed by the immune system. Tavalisse is also being studied in the treatment of other conditions and types of cancer. It blocks an enzyme called Syk, which may help keep the immune system from destroying platelets. Tavalisse is a type of tyrosine kinase inhibitor. Also called fostamatinib disodium, R788 sodium, and Syk kinase inhibitor R-935788.

Table 1. Record
IdentifierMLC-T-ONC-008532
FieldOncology and biomedicine
Synonymsfostamatinib disodium; R788 sodium; Syk kinase inhibitor R-935788
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008532",
  "term": "Tavalisse",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat thrombocytopenia (a low blood platelet count) in adults with chronic immune thrombocytopenia (ITP) that did not get better with other treatment. ITP is a condition in which platelets are destroyed by the immune system. Tavalisse is also being studied in the treatment of other conditions and types of cancer. It blocks an enzyme called Syk, which may help keep the immune system from destroying platelets. Tavalisse is a type of tyrosine kinase inhibitor. Also called fostamatinib disodium, R788 sodium, and Syk kinase inhibitor R-935788.",
  "synonyms": [
    "fostamatinib disodium",
    "R788 sodium",
    "Syk kinase inhibitor R-935788"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tavalisse/"
}

Record 16,017 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.